Punita Christopher, Fred K Chen, Varalakshmi Wuyyuru, Jose Sahel,

Slides:



Advertisements
Similar presentations
Human Visual System and Retinal Blindness Retina is a light sensitive neural network Diseases such as Retinitis Pigmentosa (RP) and Age- related Macular.
Advertisements

The Bionic Eye JON GOLDBERG, BME 181 SECTION 3. The Problem The Photoreceptor ◦Photoreceptors signal the presence of light in the visual field. ◦Rods:
Artificial Retina Imaging for the Sight Impaired For someone who has lost their sight to retinitis pigmentosa a retinal implant can be inserted. This implant.
The Bionic Eye Department of Electrical, Computer, and Biomedical Engineering – BME 181 Andrew Rosenberg.
DOE Artificial Retina Program Mark S. Humayun, M.D. Ph.D. Professor of Ophthalmology, Biomedical Engineering, and Cell & Neurobiology Doheny Eye Institute.
Artificial vision Tehisnägemine Mihhail Šubin Tallinna Tehnikaülikool, 2010.
Bionic Vision 1By Elliot Whaley, Villanova University.
Current and Upcoming Clinical Trials Now, let’s consider 2 treatments where few or no photoreceptor cells remain alive. Possible treatments here would.
Swapneel Bobade – BOSKF93.  Technology is constantly changing in today’s world; different technologies are available for various purposes.  Bionic Vision.
Bionic Vision 1By Elliot Whaley, Villanova University.
Artificial Vision A vital component of transhumanism.
Application of MEMS in Optobionics: Retinal Implant
Selective Adaptation using Electrical Stimulation Devyani Nanduri 2, J. D. Weiland1,2, A. Horsager 1, M. S. Humayun 1, 2, R. J. Greenberg 4, M. J. McMahon.
LET’S TALK LOW VISION Suleiman Alibhai, O.D. Retina Group of Washington Krista M. Davis, O.D., F.A.A.O. Columbia Lighthouse for the Blind.
T ALLINN U NIVERSITY OF T ECHNOLOGY Kirill Sergejev Tallinn 2010 B LIND PEOPLE. A RTIFICIAL V ISION ?
VISUAL PROSTHESIS By Richard Jones and David Henley.
Current Research Projects Gary S. Rubin, PhD Helen Keller Professor of Ophthalmology UCL Institute of Ophthalmology Low Vision Patient Day 7 June 2014.
When a person has lost their sight to a damaged retina there is now technology that allows them to see again. By means of a chip which sends electrical.
Retinitis pigmentosa (RP) is a group of inherited diseases that damage the light-sensitive rods and cones located in the retina, the back part of our eyes.
1 Low Vision Rehabilitation Suleiman Alibhai, O.D. Doctor of Optometry Lions Clubs International IAG Mission Myanmar, 2013.
Augmented Reality in a Contact Lens Jahdiel Franco BME 482.
Video Eyewear for Augmented Reality Presenter: Manjul Sharma Supervisor: Paul Calder.
ARTIFICIAL VISION (USING INTELLIGENT INSTRUMENTATION)
Neuroprosthetics Week 8 Visual Neuroprostheses. History Brindley (Cambridge) tried a series of experiments in the 1950s – limited success, but opened.
Presented by: Sarah Wong Orthoptist II Orthoptic Unit QA 2011.
ARTIFICIAL EYE By U.Sandhya Rani 08A91A04A7.
Integrated Controls Overview Allison Fracchia George Gober.
Bionic Vision Brining together computer science, engineering and biology Elliot Whaley Department of Computer Sciences Villanova University Major Areas.
By: Andrew Seitler.  Practical retinal prosthesis for people afflicted with progressive loss of photoreceptor cells.  Retinal chip implanted on the.
Presentation Overview
The Argus II By: Ahmaad Randall. What is it? The world’s first approved device intended to restore some functional vision for people suffering from blindness.
Bionic Eyes Robert Blease. Target Current designs are made for patients with degenerative eye disorders. The most common disorder currently treatable.
Retinal and Cortical Implants. Stat 19 SEM Talk 4. The brain is a network of nerve cell, neurons. The neurons communicate by electrical and.
By Justin Martin.  Affects thousands of people each year  Retinitis Pigmentosa is the leading cause of inherited blindness. ◦ 1.5 million people are.
Public Hearing FDA Regulation of Combination Products November 25, 2002 Risk Classification of Combination Products (Biologic/Device) Zorina Pitkin, Ph.D.
Brain Chips.
Brain/Computer Interfacing James Wilson COMP /28/07.
«Ensuring earlier visual rehabilitation for patients with visual loss» Mona Nordvik Nurse and Quality coordinator Department of Ophthalmology Haukeland.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Senses Clinical Day.
By: Kyle Sexton BME 281, Section 2 October 2, 2012.
Artificial Retina Imaging for the Sight Impaired
CONTENTS INTRODUCTION WHO IS ELIGIBLE ? DEVICE WORKING
Augmentative and Alternative Communication Taylor Cokley.
ARTIFICIAL VISION –A BIONIC EYE. INTRODUCTION ‘Bionoic eye’ also called a ‘BioElecronic eye’, is the electronic device that replaces functionality of.
The ‘Bionic’ Eye A PowerPoint Presentation By MD. ABDUR RAZZAK.
R. Angeline Prabha & J.Lavina Mary FINAL ECE JACSI COLLEGE OF ENGG. NAZARETH.
Artificial Eye By Utkarsh Anurag (EIC-3).
Southwest Center for Microsystems Education
Artificial Retina Imaging for the Sight Impaired MONDAY, APRIL 18 MIKE VUE ARTIFICIAL RETINA ALLOWS SOMEONE WHO HAS LOST THEIR VISION TO SEE AGAIN. THE.
Invest. Ophthalmol. Vis. Sci ;57(11): doi: /iovs Figure Legend:
Southwest Center for Microsystems Education
BATCH C2 Vibhor jain Mainak chakraborty Rohan seth
ARTIFICIAL EYE
Artificial Retina Imaging For The Sight Impaired: Sensors and Transducers Robert Jubie April 14th, 2017.
Information Computer Technology
Information Computer Technology
EPI-RET: IIP Animal experiment
From: Retinal Prosthesis Safety: Alterations in Microglia Morphology due to Thermal Damage and Retinal Implant Contact Invest. Ophthalmol. Vis. Sci ;53(12):
BIO SMART SENSORS ..
From: One-Year Outcome of 49-Channel Suprachoroidal–Transretinal Stimulation Prosthesis in Patients With Advanced Retinitis Pigmentosa Invest. Ophthalmol.
An Overview on the Artificial Eye (Using MEMS Technology)
Endoscope-Assisted and Controlled Argus II Epiretinal Prosthesis Implantation in Late-Stage Retinitis Pigmentosa: A Report of 2 Cases Case Rep Ophthalmol.
Contents Abstract Introduction VRD (Virtual Retinal Display) Basics
An Update on the Bionic Eye Project
Senses Clinical Day link.
BIONIC EYE BY ROBIN CHAUHAN.
Retinitis Pigmentosa Course Title : Molecular diagnostic Unit : II
BIONIC EYE. HAMZA YOUSAF HAMZA YOUSAF 18-ME ME-113 ASAD RASOOL ASAD RASOOL 18-ME ME-116 IMRAN KHAN IMRAN KHAN 18-ME ME-119 Presented.
Presentation transcript:

Punita Christopher, Fred K Chen, Varalakshmi Wuyyuru, Jose Sahel, The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss Lyndon da Cruz, Brian F Coley, Jessy Dorn, Francesco Merlini, Eugene Filley, Punita Christopher, Fred K Chen, Varalakshmi Wuyyuru, Jose Sahel, Paulo Stanga, Mark Humayun, Robert J Greenberg, Gislin Dagnelie, for the Argus II Study Group The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss Lyndon da Cruz,1 Brian F Coley,2 Jessy Dorn,3 Francesco Merlini,2 Eugene Filley,4 Punita Christopher,3 Fred K Chen,1,5 Varalakshmi Wuyyuru,3 Jose Sahel,6 Paulo Stanga,7 Mark Humayun,3,8 Robert J Greenberg,3 Gislin Dagnelie,9 for the Argus II Study Group Br J Ophthalmol 2013;0:1–5. doi

Overview Clinical Problem : RP Overview of Retinal Prosthesis Argus II Basic Design and function Aim Methods Results Discussion Challenges/Limitations Conclusion Questions

Retinitis Pigmentosa Retinitis pigmentosa is a condition that can be caused by a myriad of different gene defects (about 90 for isolated RP and RP that occurs in syndromes), with different ways of inheritance (20% autosomal-dominant [50% of children of parents who carry the defect will get RP], 20% autosomal-recessive [25% of carrying parents], 10% x-linked [mothers pass it on to sons only], and 50% spontaneous without family inheritance). It affects about one in 4000 humans, and about one in 100 are carriers. Some syndromes show RP together with other symptoms, most often hearing loss. What happens in a nutshell is that dark pigments are deposited in the retina, mostly in the area of the rods, which die off by apoptosis, so the earliest symptoms tend to be increasing loss of night vision, and the development of tunnel vision. Here’s an image of a normal retina, and one with retinitis pigmentosa :

Retinal Prosthesis History Charles LeRoy in 1755 discharged a large capacitor through the head of a blind person, who described “flames descending downwards” (Marg, 1991)

Retinal Prosthesis Concept

Retinal Prosthesis Options Argus II Visual Cortical Implant Virtual Retinal Display (VRD) Microsystem-based Visual Prosthesis (MIVIP) Artificial Silicon Retina (ASR) Tübingen MPDA Project Alpha IMS Implantable Miniature Telescope Dobelle Eye

The external equipment The external equipment includes glasses, a video processing unit (VPU) and a cable.

How Is Argus® II Designed To Produce Sight?

Testimonials The F.D.A. Approves a Bionic Eye: Argus II Device Helps the Blind – YouTube Argus II, Manchester User Testimonial - Artificial Retina - Bionic Eye - YouTube

Aim To determine whether a group of patients blinded by outer retinal dystrophies and fitted with the Argus II system, could identify letters and words on a computer screen. (effective spatial resolution, in the context of a device that is stable, portable and capable of long-term function)

Subjects

Methods Test I: letter identification Test II: letter size reduction Test III: word recognition Conditions : System off and both eyes unpatched; system on in ‘scrambled’ mode with eyes patched and unpatched; and system in standard mode with eyes patched and unpatched

Results

Figure 2 Figure 2 Box and whisker graphs illustrating the median percentage correct and quartiles for Test I letter Groups A, B and C comparing the device on and off. For Groups A, B and C, n=21, 19 and 20, respectively. (** <0.001 Wilcoxon signed rank test). Outliers, shown as black dots, are data with values beyond the ends of the whiskers.

Figure 3 Figure 3 A graph showing the mean and SEs of the total number of letters identified correctly in two test runs of letter size reduction using the Argus II retinal prosthesis system. (*p<0.05).

Challenges Safety Surgery Effectiveness Suitability Cost Contraindications Electrodes packaging

Conclusion Multiple blind subjects fitted with the Argus II system consistently identified letters and words using the device, indicating reproducible spatial resolution. This, in combination with stable, long-term function, represents significant progress in the evolution of artificial sight.

Questions What is Argus II ? What are advantages of Argus II? Argus II has therapeutic potential for what other types of retinal diseases? Argus II vs. other Retinal Prosthesis What experiments would you suggests to further test effectiveness of Argus II?